We are live on
!
Find out more
NTC
North Tide Capital Portfolio holdings
AUM
$469M
1-Year Est. Return
6.57%
This Fund
S&P 500
This Quarter
Est. Return
+12.59%
1 Year Est. Return
+6.57%
3 Year Est. Return
+14.81%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.19B
AUM Growth
+$45.6M
(+4%)
Cap. Flow
-$72.3M
Cap. Flow
% of AUM
-6.09%
Top 10 Holdings %
Top 10 Hldgs %
75.37%
Holding
31
New
3
Increased
12
Reduced
6
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SEM
Select Medical
SEM
|
+$78.2M |
| 2 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$34M |
| 3 |
AGN
Allergan Inc
AGN
|
+$30.4M |
| 4 |
Community Health Systems
CYH
|
+$20M |
| 5 |
Myriad Genetics
MYGN
|
+$15.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Labcorp
LH
|
+$45.7M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$35.1M |
| 3 |
Viatris
VTRS
|
+$31.6M |
| 4 |
Boston Scientific
BSX
|
+$31.5M |
| 5 |
CONMED
CNMD
|
+$14.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 85.81% |
| 2 | Consumer Discretionary | 1.81% |
| 3 | Industrials | 1.35% |
| 4 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SEM
1
DELISTED
Select Medical
SEM
| $174M | 14.63% |
25,891,200
+12,899,200
| +99% | +$78.2M |
|
2
Teva Pharmaceuticals
TEVA
$37.3B
| $159M | 13.35% |
3,000,000
+250,000
| +9% | +$11.6M |
|
|
AGN
3
DELISTED
Allergan Inc
AGN
| $86.9M | 7.32% |
700,000
+250,000
| +56% | +$30.4M |
|
4
Elevance Health
ELV
$80.9B
| $84.6M | 7.13% |
850,000
-50,000
| -6% | -$4.52M |
|
|
AGN
5
DELISTED
Allergan plc
AGN
| $82.3M | 6.94% |
400,000
-50,000
| -11% | -$9.9M |
|
|
WCG
6
DELISTED
Wellcare Health Plans, Inc.
WCG
| $79.4M | 6.69% |
1,250,000
+525,000
| +72% | +$34M |
|
|
TVTY
7
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $66M | 5.56% |
3,850,000
| – | – |
|
8
Quest Diagnostics
DGX
$23.3B
| $57.9M | 4.88% |
1,000,000
| – | – |
|
|
NUVA
9
DELISTED
NuVasive, Inc.
NUVA
| $57.6M | 4.85% |
1,500,000
-200,000
| -12% | -$7.35M |
|
|
AMED
10
DELISTED
Amedisys
AMED
| $47.6M | 4.01% |
3,200,000
| – | – |
|
|
KND
11
DELISTED
Kindred Healthcare
KND
| $35.1M | 2.96% |
1,500,000
+500,000
| +50% | +$10.3M |
|
|
12
Myriad Genetics
MYGN
$584M
| $34.2M | 2.88% |
1,000,000
+500,000
| +100% | +$15.5M |
|
13
Orthofix Medical
OFIX
$468M
| $34M | 2.86% |
1,127,300
+452,300
| +67% | +$10.4M |
|
|
ELOS
14
DELISTED
Syneron Medical Ltd
ELOS
| $30.6M | 2.58% |
2,460,300
+110,300
| +5% | +$1.31M |
|
|
MGLN
15
DELISTED
Magellan Health Services, Inc.
MGLN
| $29.7M | 2.5% |
500,000
-100,000
| -17% | -$5.96M |
|
|
16
Viatris
VTRS
$20.1B
| $24.4M | 2.06% |
500,000
-650,000
| -57% | -$31.6M |
|
|
17
Boston Scientific
BSX
$65.4B
| $21.6M | 1.82% |
1,600,000
-2,400,000
| -60% | -$31.5M |
|
|
AFAM
18
DELISTED
Almost Family Inc
AFAM
| $21.5M | 1.81% |
930,000
+172,601
| +23% | +$4.89M |
|
|
19
Community Health Systems
CYH
$465M
| $19.6M | 1.65% |
+605,000
| New | +$20M |
|
|
AH
20
DELISTED
Accretive Health
AH
| $16M | 1.35% |
2,000,000
+1,650,000
| +471% | +$14.6M |
|
|
SVU
21
DELISTED
SUPERVALU Inc.
SVU
| $13.7M | 1.15% |
285,714
+92,857
| +48% | +$4.14M |
|
22
Accuray
ARAY
$30.8M
| $4.8M | 0.4% |
500,000
+300,000
| +150% | +$2.84M |
|
|
GTIV
23
DELISTED
GENTIVA HEALTH SERVICES INC
GTIV
| $4.56M | 0.38% |
+500,000
| New | +$5.29M |
|
|
GHDX
24
DELISTED
Genomic Health, Inc.
GHDX
| $2.63M | 0.22% |
+100,000
| New | +$2.87M |
|
25
Cross Country Healthcare
CCRN
$428M
| – | – |
-675,000
| Closed | -$6.74M |
|
Similar funds
SD
DG
NBC
JWM
JPCCM
MCL
GIIO
FC
North Tide Capital's Q1 2014 Portfolio in Review
As of Q1 2014, North Tide Capital held 31 positions worth $1.19B, up 4% from $1.14B the previous quarter. Its ten largest holdings account for 75% of the portfolio.
North Tide Capital withdrew a net $72.3M in Q1 2014, closing 7 positions and reducing 6 holdings. Its most notable exit was Labcorp, an estimated $45.7M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 86% of assets, up from 79% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, North Tide Capital opened a new position in Community Health Systems worth $19.6M.
- North Tide Capital's largest Q1 2014 buy was Community Health Systems: 605,000 shares worth $19.6M.
- North Tide Capital added most to Select Medical in Q1 2014, an estimated $78.2M increase.
- North Tide Capital's biggest Q1 2014 reduction was Viatris, cutting an estimated $31.6M.
- North Tide Capital fully exited Labcorp in Q1 2014, selling an estimated $45.7M.
- North Tide Capital's ten largest holdings make up 75% of its $1.19B portfolio in Q1 2014.
- North Tide Capital opened 3 new positions and closed 7 in Q1 2014.
- North Tide Capital's portfolio value rose 4% quarter-over-quarter to $1.19B.
Based on North Tide Capital's 13F filing for Q1 2014, filed 15 May 2014.